Dark Forest Capital Management’s ImmunityBio IBRX Stock Holding History

Dark Forest Capital Management’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Buy	209,163 +189,382	+957%	+$1.43M	0.12%	311
2026 Q1	$152K	Buy	+19,781	New	+$135K	0.01%	750
2025 Q1	–	Sell	-25,144	Closed	-$64.4K	–	1325
2024 Q4	$64.4K	Buy	+25,144	New	+$105K	0.01%	871
2024 Q2	–	Sell	-45,433	Closed	-$244K	–	767
2024 Q1	$244K	Buy	+45,433	New	+$206K	0.04%	539
2023 Q3	–	Sell	-203,659	Closed	-$566K	–	1179
2023 Q2	$566K	Buy	203,659 +203,634	+814,536%	+$576K	0.05%	586
2023 Q1	$46	Buy	+25	New	+$78	﹤0.01%	1132
2022 Q1	–	Sell	-46	Closed	–	–	1505
2021 Q4	$0	Buy	+46	New	+$346	﹤0.01%	1587
2021 Q3	–	Sell	-3,692	Closed	-$53K	–	1392
2021 Q2	$53K	Buy	+3,692	New	+$61K	0.02%	438

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dark Forest Capital Management's IBRX Position: Q2 2026 in Review

Dark Forest Capital Management increased its ImmunityBio (IBRX) stake by 957% in Q2 2026, buying an estimated $1.43M and bringing the position to 209,163 shares worth $1.83M. The position accounts for 0.12% of the portfolio, ranked #311.

Dark Forest Capital Management first reported a position in IBRX in Q2 2021 and has held it in 8 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Dark Forest Capital Management held 209,163 shares of ImmunityBio worth $1.83M as of Q2 2026.
Dark Forest Capital Management bought 189,382 ImmunityBio shares in Q2 2026, an estimated $1.43M.
ImmunityBio made up 0.12% of Dark Forest Capital Management's portfolio in Q2 2026, its #311 holding.
Dark Forest Capital Management first reported a position in ImmunityBio in Q2 2021 and has held it in 8 quarters since.
405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.